Site-Specific Immunomodulator: A Novel Treatment for Crohn's Disease

We investigated the mechanism of action, safety, and efficacy of the Site-Specific Immunomodulator (SSI) QBECO, a novel immunotherapy for Crohn's disease (CD). Using human monocytic THP-1 cells, we demonstrate that SSI QBECO (derived from the common colon bacteria E. coli) activates macrophages...

Descripción completa

Detalles Bibliográficos
Autores principales: Bressler, Brian, Bethel, Kevin P., Kleef, Ralf, Reynolds, Sophie L., Sutcliffe, Simon, Mullins, David W., Gunn, Hal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443884/
https://www.ncbi.nlm.nih.gov/pubmed/26064087
http://dx.doi.org/10.1155/2015/231243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443884/
https://www.ncbi.nlm.nih.gov/pubmed/26064087
http://dx.doi.org/10.1155/2015/231243

Ejemplares similares